R. Keller

4.4k total citations · 1 hit paper
137 papers, 2.9k citations indexed

About

R. Keller is a scholar working on Pulmonary and Respiratory Medicine, Electrical and Electronic Engineering and Atomic and Molecular Physics, and Optics. According to data from OpenAlex, R. Keller has authored 137 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 33 papers in Electrical and Electronic Engineering and 24 papers in Atomic and Molecular Physics, and Optics. Recurrent topics in R. Keller's work include Escherichia coli research studies (15 papers), Silicon and Solar Cell Technologies (13 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers). R. Keller is often cited by papers focused on Escherichia coli research studies (15 papers), Silicon and Solar Cell Technologies (13 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers). R. Keller collaborates with scholars based in Germany, Brazil and United States. R. Keller's co-authors include Luíz Rachid Trabulsi, Tânia A. T. Gomes, Rolf Engleman, Edward F. Zalewski, John C. Travis, Peter K. Schenck, G. G. Luther, Th. Wichert, M. Deicher and Nino Künzli and has published in prestigious journals such as Physical Review Letters, The Journal of Chemical Physics and SHILAP Revista de lepidopterología.

In The Last Decade

R. Keller

129 papers receiving 2.7k citations

Hit Papers

Typical and Atypical EnteropathogenicEscherichia coli 2002 2026 2010 2018 2002 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Keller Germany 29 906 837 591 554 413 137 2.9k
Kevin Killeen United States 31 717 0.8× 415 0.5× 435 0.7× 344 0.6× 435 1.1× 84 3.2k
J. E. Williams United States 37 141 0.2× 335 0.4× 134 0.2× 957 1.7× 589 1.4× 273 5.3k
Yoshikazu Ishii Japan 35 877 1.0× 770 0.9× 223 0.4× 139 0.3× 220 0.5× 261 4.4k
Charles C. Kim United States 38 377 0.4× 533 0.6× 384 0.6× 251 0.5× 474 1.1× 94 4.8k
Satoru Matsumoto Japan 38 351 0.4× 436 0.5× 1.2k 2.0× 619 1.1× 150 0.4× 339 7.6k
Toshio Takahashi Japan 39 409 0.5× 430 0.5× 86 0.1× 242 0.4× 827 2.0× 399 6.1k
W. A. Gillespie United Kingdom 35 162 0.2× 512 0.6× 778 1.3× 772 1.4× 103 0.2× 178 3.5k
Klaus Winzer Germany 50 1.0k 1.1× 781 0.9× 165 0.3× 471 0.9× 495 1.2× 218 9.9k
John Anderson United States 34 499 0.6× 1.5k 1.8× 156 0.3× 61 0.1× 210 0.5× 202 3.8k
Werner Fischer Germany 49 219 0.2× 1.0k 1.2× 412 0.7× 227 0.4× 997 2.4× 270 8.6k

Countries citing papers authored by R. Keller

Since Specialization
Citations

This map shows the geographic impact of R. Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Keller more than expected).

Fields of papers citing papers by R. Keller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Keller. The network helps show where R. Keller may publish in the future.

Co-authorship network of co-authors of R. Keller

This figure shows the co-authorship network connecting the top 25 collaborators of R. Keller. A scholar is included among the top collaborators of R. Keller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Keller. R. Keller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Keller, R., et al.. (2021). Prebiotics mannan-oligosaccharides accelerate sexual maturity in rats: A randomized preclinical study. Veterinary World. 14(5). 1210–1219. 10 indexed citations
4.
Giuffrida, Rogério, et al.. (2018). Systematic review and meta-analysis of preclinical trials demonstrate robust beneficial effects of prebiotics in induced inflammatory bowel disease. The Journal of Nutritional Biochemistry. 62. 1–8. 14 indexed citations
5.
Keller, R., et al.. (2015). AVALIAÇÃO DE CONSERVAÇÃO DA VIABILIDADE DE STAPHYLOCOCCUS AUREUS E ESCHERICHIA COLI SOB INFLUÊNCIA DE FLUÍDOS BIOLÓGICOS EM SUPERFÍCIES SECAS. SHILAP Revista de lepidopterología. 1 indexed citations
6.
Watanabe, Erika, Fernando Gomes Romeiro, Lígia Yukie Sassaki, R. Keller, & Josias Rodrigues. (2012). Enteroaggregative Escherichia Coli Seems to Proliferate in the Terminal Portion of The Colon of IBD Patients. Inflammatory Bowel Diseases. 18. 1 indexed citations
7.
Fischer, Gerhard, et al.. (2005). Vergleich der Messverfahren zur Bestimmung von MVOC in Innenr�umen. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 48(1). 43–53. 1 indexed citations
8.
Keller, R., et al.. (2000). Content of mycotoxins in conidiospores from mould in buildings. Mycotoxin Research. 16(S1). 88–93. 2 indexed citations
9.
Keller, R., Elizabeth L. Hartland, Miranda Batchelor, et al.. (2000). Human Colostrum and Serum Contain Antibodies Reactive to the Intimin-Binding Region of the Enteropathogenic Escherichia coli Translocated Intimin Receptor. Journal of Pediatric Gastroenterology and Nutrition. 30(1). 73–77. 25 indexed citations
11.
Keeling, James H., et al.. (1999). THE DERMATOLOGIST IN MILITARY OPERATIONS. Dermatologic Clinics. 17(1). 209–234. 1 indexed citations
12.
Keller, R.. (1998). [Long-term home oxygen therapy: who? with what? how expensive?].. PubMed. 128(12). 435–41. 1 indexed citations
13.
Matthys, H, R. Keller, Hartmut Zwick, & Gabriele Barthlen. (1998). Recommendations and guidelines for long-term oxygen therapy (LTOT) of the International Respiratory Care Club (IRCC).. PubMed. 53(1). 107–9. 2 indexed citations
14.
Delank, K.-W., R. Keller, & Wolfgang Stoll. (1993). Morphologie und rhinologische Bedeutung der Intumescentia septi nasi anterior*. Laryngo-Rhino-Otologie. 72(5). 242–246. 11 indexed citations
15.
Keller, R.. (1984). [Multicenter double-blind study of the action of Broncho-Vaxom in chronic bronchitis].. PubMed. 114(25). 934–7. 5 indexed citations
16.
Kieß, H., R. Keller, D. Baeriswyl, & G. Harbeke. (1982). Photoconductivity in trans (CH)x: A proof for the existence of solitons?. Solid State Communications. 44(10). 1443–1447. 15 indexed citations
17.
Keller, R., et al.. (1981). [Chylothorax associated with sarcoidosis].. PubMed. 111(4). 125–8. 3 indexed citations
18.
Keller, R., et al.. (1976). [Pulmonary circulation as a limiting factor in physical work capacity (author's transl)].. PubMed. SUPPL. 27–39. 1 indexed citations
19.
Harris, David O., et al.. (1968). PSEUDOROTATION IN FIVE MEMBERED RINGS. Virology. 410(1). 129–41. 1 indexed citations
20.
Burkard, W.P. & R. Keller. (1956). [Effects of heparin on histamine induced contraction of guinea pig ileum].. PubMed. 12(10). 394–394. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026